Physical activity in older adults with visual impairment increased by improved home lighting
February 20th 2024A new study shows that much of an older person with visual impairment's physical activity is achieved at home. Improved home lighting can help increase those at-home activity rates.
Read More
Mapping the specific progressing anatomic features from drusen to type 3 MNV
February 5th 2024Elodie Bousquet, MD, PhD, and international researchers studied type 3 macular neovascularization (T3 MNV) using optical coherence tomography. In 64.5% of 31 eyes with T3 MNV, it developed over soft drusen, showing drusen growth and outer layer thinning before T3 MNV.
Read More
Voyager study looks at real-world data of faricimab in patients with nAMD and DME
February 4th 2024A minimum of 5,000 patients with up to 5 years of follow-up will be included in the study, with patients from a variety of practice settings and clinician experiences in 28 countries and 500 sites
Read More
Very low incidence of ocular inflammatory events reported after COVID-19 vaccinations in the UK
January 26th 2024A recent study found that despite worldwide reports of ocular inflammatory events being reported after patients received COVID-19 vaccinations, a low amount has been reported in the UK.
Read More
Biosimilars to treat retinal diseases: Successful outcomes, patient satisfaction
January 23rd 2024Two retina specialists participated in an Ophthalmology Times case-based roundtable discussion and shared their experiences using the anti-VEGF biosimilars, ranibizumab-eqrn and ranibizumab-nuna to manage retinal diseases.
Read More
Pupillometry as a potential biomarker for major depressive disorder
January 17th 2024A collaborative study between the Max Planck Institute of Psychiatry and the University of California, Irvine, explores the potential of pupillometry as a clinical test for identifying a specific subgroup of patients with major depressive disorder (MDD) characterized by anticipatory hypo-arousal related to anhedonia.
Read More